Retractable Technologies Stock

Retractable Technologies EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Retractable Technologies (RVP) as of Aug 6, 2026 is -0.98. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -0.94 — a change of 4.38% (lower).

EV/EBIT

-0.98

YoY

4.38%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Retractable Technologies is 2026 -0.98 . EV/EBIT (Enterprise Value to EBIT) of Retractable Technologies was 2025 -0.94 . It decreases by 4.38% lower compared to the previous year.

The Retractable Technologies EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
-14.85 base
Jan 1, 2019
16.50 base
Jan 1, 2020
14.89 base
Jan 1, 2021
3.27 base
Jan 1, 2022
9.21 base
Jan 1, 2023
-2.89 base
Jan 1, 2024
-0.98 base
Jan 1, 2025
-1.14 base
YEARPRICE-TO-EBIT
2025 -1.14
2024 -0.98
2023 -2.89
2022 9.21
2021 3.27
2020 14.89
2019 16.50
2018 -14.85
2017 -5.88
2016 -4.06
2015 -7.17
2014 -16.62
2013 -3.67
2012 -1.56
2011 -1.89
2010 -1.60
2009 -0.76
2008 -0.50
2007 -0.94
2006 -2.64
Access this data via the Eulerpool API

Retractable Technologies Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Retractable Technologies's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Retractable Technologies's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Retractable Technologies's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Retractable Technologies grows earnings faster than its peers.

Retractable Technologies Stock analysis

What does Retractable Technologies do? Retractable Technologies Inc. is a company based in Little Elm, Texas, specializing in the design, manufacturing, and distribution of healthcare safety products. The company was founded in 1994 by Thomas J. Shaw and has played an important role in the field of medical safety technology. The company's business model is simple but effective. It produces and sells safety-related medical products that are crucial for both patients and healthcare professionals. Retractable Technologies Inc. has a variety of patented products in its portfolio to meet the needs of individuals and the healthcare industry as a whole. its comprehensive product range includes safety scalpels, IV catheters, syringes, blood collection lancets, and many other high-quality products. The history of Retractable Technologies Inc. begins with the development of the VanishPoint safety syringe in 1993 by founder Thomas J. Shaw. Unlike traditional syringes, the VanishPoint model has an automatic protective mechanism that retracts the needle inward after use, significantly reducing the risk of needlestick injuries. The product quickly became the company's best-selling product. Over the years, Retractable Technologies Inc. has continuously expanded and improved its product range, focusing on design and innovation to meet the needs of its customers and the healthcare sector as a whole. The company is divided into various segments, all aimed at improving the safety of patients and healthcare professionals. There is the safety scalpel segment, which began in 1999 with the introduction of the safety lancet line in collaboration with the American Diabetes Association. The goal was to develop a painless blood glucose test with previously unmatched safety in the handling of blood collection lancets and personalized drop protection devices. Another important segment of Retractable Technologies Inc. is the syringe category. The focus here is on reducing needlestick injuries and infections when using syringes. The patented safety mechanisms allow doctors, nurses, and other medical personnel to safely operate syringes. These products are available in various sizes to meet the requirements of infants to adults. The IV catheter category is also well positioned, as Retractable Technologies Inc.'s products reduce the number of peripheral infiltrations and catheter-associated bloodstream infections, reduce damage to blood vessels, and provide personalized safety devices. Finally, there is the tuberculin category, which focuses on measuring skin tests and allergic reactions. The category features products with enhanced safety design and is particularly popular among those who rely on this type of testing. Each patient is different and requires a customized solution to reduce the risk of injuries related to medical products. Retractable Technologies Inc. provides its customers with a high level of safety and convenience through its innovative products. The company has become a market leader in the development and manufacture of safe medical products and is committed to meeting customer needs with effective products. With a strong focus on design and innovation, Retractable Technologies Inc. continues to set the standard for safety products throughout the industry. Retractable Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Retractable Technologies stock

EV/EBIT (Enterprise Value to EBIT) of Retractable Technologies is -0.98 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Retractable Technologies changed from -0.94 to -0.98, representing a 4.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Retractable Technologies since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Retractable Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Retractable Technologies

All Key Metrics — Retractable Technologies